Back to top

Fidelity Advisor Biotechnology C: (MF: FBTIX)

(MF) As of Apr 22, 2014 06:05 PM ET

 Add to portfolio

$20.01 USD

+0.71 (3.68%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Mar 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Mar 31, 2014) 5.64
Objective* Equity - Sector Health
Peer* HL MG

*Key

Zacks Premium Research for FBTIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Buy 2
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 23.21
Net Assets (Mil $) 3/31/2014 442.44
%Turnover 3/31/2014 22.00

Allocation

% of Portfolio
Large Growth 18.99
Large Value 0.00
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 35.27
High Yield Bond 0.00

Sector / Country Weightings

As of 3/31/2014 % of Portfolio
Health 56.55
Services 24.70
Other 10.08
Industrial Cyclical 8.42
Technology 0.25

Portfolio Holdings

Top Equity Holdings
(As of 10/31/2013)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 17.28 165.92
AMGEN INC 13.39 128.61
BIOGEN IDEC INC 8.06 77.37
CELGENE CORP 7.47 71.75
ALEXION PHARMACEUTICALS I 4.97 47.70
REGENERON PHARMACEUTICALS 4.59 44.05
VERTEX PHARMACEUTICALS IN 3.38 32.48
PHARMACYCLICS INC 2.49 23.86
AEGERION PHARMACEUTICALS 2.44 23.40

Stock Holding % of Net Assets

As Of 10/31/2013
Total Issues 141
Avg. P/E 41.60
Avg. P/Book 5.73
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 45,912

Risk

3 Year 5 Year 10 Year
Beta 0.93 0.84 0.79
Alpha 23.48 11.49 7.99
R Squared 0.31 0.31 0.35
Std. Dev. 20.82 20.91 19.95
Sharpe 1.96 1.51 2.00